Calidi Biotherapeutics adds former Genentech, Celgene executive Corsee Sanders to board

Reuters2026/07/21 12:03

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Calidi Biotherapeutics added Corsee Sanders, Ph.D. to its board.
Sanders previously advised Celgene’s CMO following its Juno acquisition, where she served as EVP of Development Operations.
She later served as a transition advisor to Bristol Myers Squibb following its acquisition of Celgene.
Sanders spent 23 years at Genentech/Roche, including six years as SVP and global head of clinical operations and industry collaboration.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Calidi Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607210800PRIMZONEFULLFEED9765009) on July 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Calidi Biotherapeutics adds former Genentech, Celgene executive Corsee Sanders to board

You may also like

Crypto prices